Tuberous sclerosis complex - a case report / Kompleks tuberozne skleroze – prikaz slučaja

Nada Petrova 1 , Gjorgji Gocev 1  and Elena Angelovska 1
  • 1 University Clinic of Dermatology, Faculty of Medicine, University “Ss Kiril and Metodij”, Skopje, Republic of Macedonia


Tuberous sclerosis complex is a multisystem, autosomal dominant disorder affecting children and adults, which results from mutations in either of two genes, TSC1 (encoding hamartin) or TSC2 (encoding tuberin). Tuberous sclerosis complex often causes disabling neurologic disorders, including epilepsy, mental retardation, and autism. Major features of the disease include dermatologic manifestations, such as facial angiofibromas, renal angiomyolipomas, and pulmonary lymphangiomyomatosis. We report a 20-year-old woman with epilepsy and subnormal intelligence, who was admitted for evaluation of multiple facial papules that have gradually increased in number over the past 15 years. She had been previously diagnosed with tuberous sclerosis complex based on findings of cardiac ventricular rhabdomyomas, tuberosclerotic nodules of glial proliferation in the cerebral cortex, and renal angiomyolipoma. The facial papules were angiofibromas, confirming the clinical presentation of tuberous sclerosis complex. Detailed examination of the skin and mucosa revealed Shagreen patches, nontraumatic subungual and gingival fibroma, all features of tuberous sclerosis complex. A multidisciplinary team approach was used for diagnosis and medical care of tuberous sclerosis complex in order to treat many organ systems affected by tuberous sclerosis in our patient. The patient received antiepileptic medications, while rapamycin was recommended.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Baskin HJ Jr. The pathogenesis and imaging of the tuberous sclerosis complex. Pediatr Radiol. 2008;38(9):936-52.

  • 2. Sybert VP, Hall JG. Inheritance of tuberous sclerosis. Lancet. 1979;1:783.

  • 3. Fryer AE. Tuberous sclerosis. J R Soc Med. 1991;84(12):699-701.

  • 4. Roach ES, Gomez MR, Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol. 1998;13:624-8.

  • 5. Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med. 2006;355:1345-56.

  • 6. Webb DW, Clarke A, Fryer A, et al. The cutaneous featuresof tuberous sclerosis: a population study. Br J Dermatol. 1996;135:1-5.

  • 7. Gutowski NJ, Murphy RP. Late onset epilepsy in undiagnosed tuberous sclerosis. Postgrad Med J. 1992;68(806):970-1.

  • 8. Goodman M, Lamm SH, Engel A, Shepherd CW, Houser OW, Gomez MR. Cortical tuber count: a biomarker indicating neurologic severity of tuberous sclerosis complex. J Child Neurol. 1997;12:85-90.

  • 9. Mizuguchi M, Takashima S. Neuropathology of tuberous sclerosis. Brain Dev. 2001;23:508-15.

  • 10. Prather P, de Vries PJ. Behavioral and cognitive aspects of tuberous sclerosis complex. J Child Neurol. 2004;19(9):666-74.

  • 11. Stillwell TJ, Gomez MR, Kelalis PP. Renal lesions in tuberous sclerosis. J Urol. 1987;138(3):477-81.

  • 12. Bernstein J, Robbins TO, Kissane JM. The renal lesions of tuberous sclerosis. Semin Diagn Pathol. 1986;3(2):97-105.

  • 13. Roach ES, Sparagana SP. Diagnosis of tuberous sclerosis complex. J Child Neurol. 2004;19:643-9.

  • 14. Smythe JF, Dyck JD, Smallhorn JF, Freedom RM. Natural history of cardiac rhabdomyoma in infancy and childhood. Am J Cardiol. 1990;66:1247-9.


Journal + Issues